Biotech · Public company · San Diego, CA, US
Atrium Therapeutics, Inc.
Ticker RNA · SEC CIK 0002093101
Track this companyFree. Adds Atrium Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline1
- ATR 1072Phase 2 · Cardiac GlycogenosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- ATR 1072 in Participants With PRKAG2 SyndromePHASE1_PHASE2 · RECRUITING · started Sep 14, 2026ClinicalTrials.gov NCT07738107 · fetched Nov 12, 2026
SEC filings11
- 8-K · 8-KSEC EDGAR · filed Nov 2, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 27, 2026 · fetched Nov 12, 2026
- 8-K/A · 8-K/ASEC EDGAR · filed Oct 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 8, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 14, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 14, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 14, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 27, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 26, 2026 · fetched Nov 12, 2026